CareCredit and Clarus Make Checkout Simpler for Veterinary Practices with Real-Time Eligibility Insights for Insurance and Financing Options

Key Highlights: Pet insurance and financing clarity at checkout: The Clarus Technology Portal gives vet teams real-time visibility into a client's pet insurance coverage and available financing options at the point of care, helping veterinarians discuss payment confidently and quickly. More payment paths for higher treatment acceptance: By pairing the CareCredit credit card with insurance insights in one workflow, the partnership helps reduce payment friction, support clearer estimates, and aims to increase the likelihood clients proceed with recommended care.

PRNewsWire • Oct 28, 2026

Macro Concerns Grow, But Synchrony's Earnings Remain Resilient

Synchrony Financial maintains a Buy rating, supported by strong capital returns and sector-beating or in-line valuation multiples. SYF has executed aggressive share buybacks, reducing outstanding shares by over 20% in two years and returning significant capital to shareholders. Despite modest net income growth, EPS continues to rise due to buybacks, with a forward GAAP P/E of 7.83 versus the sector median of 11.56.

Seeking Alpha • Oct 24, 2026

Why Synchrony (SYF) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Oct 23, 2026

Should Value Investors Buy Synchrony Financial (SYF) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Oct 22, 2026

Synchrony (SYF) Upgraded to Buy: What Does It Mean for the Stock?

Synchrony (SYF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Oct 22, 2026

SYF or FUTU: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Financial - Miscellaneous Services sector have probably already heard of Synchrony (SYF) and Futu Holdings Limited Sponsored ADR (FUTU). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Oct 22, 2026

These Analysts Revise Their Forecasts On Synchrony Financial After Q3 Results

Synchrony Financial (NYSE:SYF) on Tuesday posted mixed results for the third quarter.

Benzinga • Oct 21, 2026

Synchrony Aces The Quarter As Credit Fears Fade

Wall Street priced Synchrony Financial NYSE: SYF for a retail credit fracture that failed to materialize in the third quarter. Heading into late 2026, the popular bearish story was that households were strained by prolonged inflation and high interest rates.

MarketBeat • Oct 21, 2026

CareCredit Introduces CareCredit Pay Later, Offering Consumers Another Way to Plan and Pay for Health and Wellness Care

CareCredit Pay Later is CareCredit's enhanced installment loan product that will be presented digitally with CareCredit's revolving credit card to give consumers additional payment options and simplified offer comparisons. Key Highlights: Supporting providers and consumer choice: Offering more payment choices can help providers meet different consumer preferences, while CareCredit manages administrative and billing workflows.

PRNewsWire • Oct 21, 2026

What Synchrony Financial (SYF) Said on Its Q3 Earnings Call

Synchrony Financial NYSE: SYF reported third-quarter net earnings of $892 million, or $2.68 per diluted share, as purchase volume reached nearly $50 billion and rose across each of the company's five sales platforms.

MarketBeat • Oct 20, 2026